Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Oronsky

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
International Journal of Molecular Sciences|May 5, 2021
RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor VasculatureVinay P Jani, Robert Asaro, Bryan Oronsky, et al.
Life Sciences in Space Research|November 6, 2022
RRx-001 and the "Right stuff": Protection and treatment in outer spaceBryan Oronsky, Scott Caroen, Nacer Abrouk, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 8, 2022
Could nucleocapsid be a next-generation COVID-19 vaccine candidate - author's replyBryan Oronsky, Christopher Larson, Scott Caroen, et al.
American Journal of Cancer Research|May 9, 2022
The small molecule NLRP3 inhibitor RRx-001 potentiates regorafenib activity and attenuates regorafenib-induced toxicity in mice bearing human colorectal cancer xenograftsTony Reid, Bryan Oronsky, Nacer Abrouk, et al.
International Journal of Medical Sciences|October 14, 2022
Superficial Venous-Associated Inflammation from Direct IV Administration of RRx-001 in RatsScott Caroen, Bryan Oronsky, Tony Reid, et al.
Neoplasia (New York, N.Y.)|September 10, 2017
What's New in SCLC? A ReviewBryan Oronsky, Tony R Reid, Arnold Oronsky, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 25, 2021
A short discussion about the SARS-CoV-2 mRNA-1273 vaccineBryan Oronsky, Harry E Gruber, Wendy Reiners, et al.
Journal of Investigative Medicine High Impact Case Reports|August 8, 2018
Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable CancerBryan Oronsky, Chris Larson, Tony R Reid, et al.
Neoplasia (New York, N.Y.)|November 2, 2017
Nothing But NET: A Review of Neuroendocrine Tumors and CarcinomasBryan Oronsky, Patrick C Ma, Daniel Morgensztern, et al.
Journal of Investigative Medicine High Impact Case Reports|March 20, 2018
A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum DoubletHope Cottrill, Stephanie Cason, Scott Caroen, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
International Journal of Molecular Sciences|May 5, 2021
RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor VasculatureVinay P Jani, Robert Asaro, Bryan Oronsky, et al.
Life Sciences in Space Research|November 6, 2022
RRx-001 and the "Right stuff": Protection and treatment in outer spaceBryan Oronsky, Scott Caroen, Nacer Abrouk, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 8, 2022
Could nucleocapsid be a next-generation COVID-19 vaccine candidate - author's replyBryan Oronsky, Christopher Larson, Scott Caroen, et al.
American Journal of Cancer Research|May 9, 2022
The small molecule NLRP3 inhibitor RRx-001 potentiates regorafenib activity and attenuates regorafenib-induced toxicity in mice bearing human colorectal cancer xenograftsTony Reid, Bryan Oronsky, Nacer Abrouk, et al.
International Journal of Medical Sciences|October 14, 2022
Superficial Venous-Associated Inflammation from Direct IV Administration of RRx-001 in RatsScott Caroen, Bryan Oronsky, Tony Reid, et al.
Neoplasia (New York, N.Y.)|September 10, 2017
What's New in SCLC? A ReviewBryan Oronsky, Tony R Reid, Arnold Oronsky, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 25, 2021
A short discussion about the SARS-CoV-2 mRNA-1273 vaccineBryan Oronsky, Harry E Gruber, Wendy Reiners, et al.
Journal of Investigative Medicine High Impact Case Reports|August 8, 2018
Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable CancerBryan Oronsky, Chris Larson, Tony R Reid, et al.
Neoplasia (New York, N.Y.)|November 2, 2017
Nothing But NET: A Review of Neuroendocrine Tumors and CarcinomasBryan Oronsky, Patrick C Ma, Daniel Morgensztern, et al.
Journal of Investigative Medicine High Impact Case Reports|March 20, 2018
A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum DoubletHope Cottrill, Stephanie Cason, Scott Caroen, et al.
Pageof 12